Skip to main content

Dare Bioscience, Inc.

corporate_fare Company Profile

Dare Bioscience, Inc.

DARE·NASDAQ·Life Sciences·CIK 0001401914

Daré Bioscience, Inc. is a health biotechnology company focused on developing solutions for women's health. The company aims to bridge the gap between scientific advancements and practical applications in areas such as contraception, menopause, pelvic pain, fertility, vaginal health, and infectious diseases. Daré operates as a female-led organization, concentrating on accelerating the development of science-based solutions that meet clinical rigor standards, including randomized, controlled trials, validated endpoints, peer-reviewed publications, and current Good Manufacturing Practice (cGMP) requirements. The company's objective is to introduce innovative products to the market, either as FDA-approved therapies or through alternative regulatory pathways like Section 503B compounding, to ensure earlier availability. Daré maintains a pipeline of investigational products and near-commercial products available through alternative pathways. In March 2025, the company expanded its business model to incorporate a dual-path approach for bringing new products to market.

Dare Bioscience, Inc. (NASDAQ:DARE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for DARE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for DARE spans DEF 14A, 8-K, PRE 14A, S-1.

Recent high-impact activity:

  • Dare Bioscience Sets Nov 10 Vote on 45% Warrant Dilution
  • Dare Bioscience Hit With Second Nasdaq Delisting Notice — Now Below $1 Minimum Bid Price
  • Dare Bioscience Seeks Stockholder Approval for Warrant Exercise That Could Dilute Shares by 45%
  • Dare Bioscience Registers Resale of 8.9M Warrant Shares From $6M Offering
  • Dare Bioscience Details $6M Offering: Warrants, Fees, and Lock-Ups

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.03M
Net Income
-$13.4M
Diluted EPS
-$1.20
Op. Cash Flow
-$9.89M
Free Cash Flow
-$10.27M
Gross Profit
$734.39K
Operating Income
-$13.55M
Cash & Equivalents
$24.71M
Debt / Equity
0.00×
Net Margin
-13.01×
Shares Outstanding
14.5M sh
Source: 10-K · filed 2026-03-26 · accession 0001401914-26-000004

Short Interest & Short Volume

6.07 days to cover

FINRA reported short interest of 986,092 shares in DARE as of the October 30, 2026 settlement, a 13.8% decrease from the prior period — about 6.1 days to cover at its recent average daily volume. On November 20, 2026, 23.1% of DARE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)986,092 shares as of October 30, 2026
Change vs prior period▼ 13.8%
Days to cover6.07 at avg daily volume of 162,380
Daily short volume (FINRA facilities)23.1% of 109,554 shares on November 20, 2026
5-day average short volume40.9%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for DARE, detected from its recent SEC filings · based on capital-structure filings through 2026-08-17.

1 recent capital raise1 shelf registration

Registered Direct Offering Priced · Concurrent Private Placement Warrants

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with D →
$0.417 +2.34% today
52-week range · as of 2026-10-06 $0.417 – $3.78
Market cap
$8.01M
Volume
173.2K (1.0× avg)
3-mo avg 172.9K
Live data · 2026-11-22 03:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DARE - Latest Insights

DARE
Oct 06, 2026, 5:00 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.844
Real-time Price: $0.417 info
Change: -$0.427 (-51%) info
Market Cap: $8.014M info
DARE
Oct 02, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8428
Real-time Price: $0.417 info
Change: -$0.4258 (-51%) info
Market Cap: $8.014M info
DARE
Sep 23, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.8074
Real-time Price: $0.417 info
Change: -$0.3904 (-48%) info
Market Cap: $8.014M info
DARE
Aug 26, 2026, 5:15 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $0.810
Real-time Price: $0.417 info
Change: -$0.393 (-49%) info
Market Cap: $8.014M info
DARE
Aug 17, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.900
Real-time Price: $0.417 info
Change: -$0.483 (-54%) info
Market Cap: $8.014M info
DARE
Aug 17, 2026, 8:30 AM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $0.900
Real-time Price: $0.417 info
Change: -$0.483 (-54%) info
Market Cap: $8.014M info
DARE
Aug 14, 2026, 12:45 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.417 info
Change: -$0.723 (-63%) info
Market Cap: $8.014M info
DARE
Aug 13, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $0.417 info
Change: -$1.22 (-75%) info
Market Cap: $8.014M info
DARE
Aug 13, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $0.417 info
Change: -$0.953 (-70%) info
Market Cap: $8.014M info
DARE
Aug 13, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.37
Real-time Price: $0.417 info
Change: -$0.953 (-70%) info
Market Cap: $8.014M info
DARE
Jul 17, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.90
Real-time Price: $0.417 info
Change: -$1.48 (-78%) info
Market Cap: $8.014M info
DARE
Jul 17, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.96
Real-time Price: $0.417 info
Change: -$1.54 (-79%) info
Market Cap: $8.014M info
DARE
Jun 22, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.19
Real-time Price: $0.417 info
Change: -$1.77 (-81%) info
Market Cap: $8.014M info
DARE
Jun 12, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.02
Real-time Price: $0.417 info
Change: -$1.60 (-79%) info
Market Cap: $8.014M info
DARE
May 26, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $0.417 info
Change: -$1.98 (-83%) info
Market Cap: $8.014M info
DARE
May 14, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.84
Real-time Price: $0.417 info
Change: -$2.42 (-85%) info
Market Cap: $8.014M info
DARE
May 14, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.95
Real-time Price: $0.417 info
Change: -$2.53 (-86%) info
Market Cap: $8.014M info
DARE
May 12, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $2.53
Real-time Price: $0.417 info
Change: -$2.11 (-84%) info
Market Cap: $8.014M info
DARE
May 07, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.97
Real-time Price: $0.417 info
Change: -$2.56 (-86%) info
Market Cap: $8.014M info
DARE
Apr 28, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $0.417 info
Change: -$1.70 (-80%) info
Market Cap: $8.014M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets